Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 4 Breast Neoplasms 4 Sarcoma 3 Melanoma 3 Gastrointestinal Stromal Tumors 3 Colorectal Neoplasms 3 Stomach Neoplasms 2 Ovarian Neoplasms 2 Liver Neoplasms 2 Head and Neck Neoplasms 2 Gastrointestinal Neoplasms 2 Cholangiocarcinoma 2 Carcinoma, Renal Cell 2 Carcinoma, Non-Small-Cell Lung 2 Uterine Cervical Neoplasms 1 Thyroid Neoplasms 1 Small Cell Lung Carcinoma 1 Prostatic Neoplasms 1 Neoplasms 1 Neoplasm Metastasis 1 Lung Neoplasms 1 Kidney Neoplasms 1 Hypertension 1 Glioblastoma 1 Gallbladder Neoplasms 1 Colonic Neoplasms 1 Central Nervous System Neoplasms 1 Carcinoma, Hepatocellular 1 Advanced Gastric Cancer 1

Interventions

apatinib 9 Paclitaxel 9 Capecitabine 7 Oxaliplatin 6 camrelizumab 5 Cisplatin 5 S 1 (combination) 4 Fluorouracil 3 Docetaxel 3 130-nm albumin-bound paclitaxel 3 titanium silicide 2 Leucovorin 2 Drug Therapy 2 vorolanib 1 trifluridine tipiracil drug combination 1 tipiracil 1 spartalizumab 1 rucaparib 1 relatlimab 1 raltitrexed 1 pazopanib 1 olaparib 1 lobaplatin 1 linrodostat 1 ezogabine 1 endostar protein 1 durvalumab 1 dacomitinib 1 capivasertib 1 Trifluridine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Gastric Cancer × pazopanib × Gastrointestinal × Clear all

NCT01503372 2019-02-12

PaFLO

Charite University, Berlin, Germany

Phase 2 Completed

Gastrointestinal

Advanced Gastric Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡